(Q40527373)

English

Yellow fever 17D virus: pseudo-revertant suppression of defective virus penetration and spread by mutations in domains II and III of the E protein

scientific article published on September 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Yellow fever 17D virus: pseudo-revertant suppression of defective virus penetration and spread by mutations in domains II and III of the E protein (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

yellow fever virus

0 references

1 reference

based on heuristic

inferred from title

author name string

Leonssia Vlaycheva

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Michael Nickells

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Deborah A Droll

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Thomas J Chambers

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

1 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

327

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

41-49

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Epitopes on the dengue 1 virus envelope protein recognized by neutralizing IgM monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.015

7 January 2021

Biophysical Characterization and Vector-Specific Antagonist Activity of Domain III of the Tick-Borne Flavivirus Envelope Protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.015

7 January 2021

Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.015

7 January 2021

Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.015

7 January 2021

Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.015

7 January 2021

Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.015

7 January 2021

Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.015

7 January 2021

Mutations in the envelope protein of Japanese encephalitis virus affect entry into cultured cells and virulence in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.015

7 January 2021

Structures and mechanisms in flavivirus fusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.015

7 January 2021

Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.015

7 January 2021

Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.015

7 January 2021

Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.015

7 January 2021

Changes in the dengue virus major envelope protein on passaging and their localization on the three-dimensional structure of the protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.015

7 January 2021

Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.015

7 January 2021

Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.015

7 January 2021

A ligand-binding pocket in the dengue virus envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.015

7 January 2021

Structure of the dengue virus envelope protein after membrane fusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.015

7 January 2021

Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.015

7 January 2021

Interaction of yellow fever virus French neurotropic vaccine strain with monkey brain: characterization of monkey brain membrane receptor escape variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.015

7 January 2021

Neuroadapted Yellow Fever Virus 17D: Determinants in the Envelope Protein Govern Neuroinvasiveness for SCID Mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.015

7 January 2021

The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.015

7 January 2021

Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.015

7 January 2021

Neuroblastoma Cell-Adapted Yellow Fever 17D Virus: Characterization of a Viral Variant Associated with Persistent Infection and Decreased Virus Spread

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.015

7 January 2021

Identifiers

10.1016/J.VIROL.2004.06.015

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40527373&oldid=1899998712"